Transvaginal Mesh

News Alert:

transvaginal_meshNovember 2014: Jurors in two separate trials sided against vaginal mesh manufacturer Boston Scientific. In a West Virginia case, the jury awarded four women who filed lawsuitsagainst the company $18.5 million. In another case in Florida, the jury awarded $26.7 million to four injured women. Thousands of lawsuits remained pending against Boston Scientific and numerous other vaginal mesh manufacturers.

These verdicts are not the only ones mesh victims have won. They represent a major victory for the thousands of women who have filed or plan to file transvaginal mesh lawsuits

Transvaginal Mesh Patch Failures

A July 2011 FDA alert warns of serious complications associated with transvaginal mesh patches when implanted to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI). That same year, the New England Journal of Medicine compared vaginal mesh to colporrhaphy, a traditional treatment of POP, and found vaginal mash carries greater risks, including:

According to the FDA, significant complications resulting from transvaginal mesh patches are not rare and commonly include:

Less frequent problems included:

If you have suffered complications due to the implantation of a transvaginal patch to treat POP or SUI, contact the experienced medical device lawyers of Childers, Schlueter & Smith, LLC for a free consultation today by calling us toll-free at (800) 641-0098 or by filling out the form on this page. All inquires are completely confidential.

Transvaginal Mesh Timeline

2011 FDA Alert: Serious and painful complications are associated with the transvaginal placement of surgical mesh, and their occurrence is not rare. The FDA also found the risky surgical mesh treatment of POP to be no more effective than traditional treatment.

2008 to 2010: FDA received 2,874 more reports of adverse complications linked to transvaginal mesh repair of POP and stress urinary incontinence (SUI). This brings the total adverse reports to over 3,800.

2010 Study: A study featured in the Obstetrics & Gynecology journal had to be terminated due to the extent of injuries to participants who received the transvaginal mesh patch. Of the women who were treated with the surgical mesh, 15 percent experienced erosions, and other complications included two cystotomies (bladder incision) and one blood transfusion.

2005 to 2008: FDA received more than 1,000 reports from nine surgical mesh manufacturers about complications related to the device and its treatment of POP and SUI.

Over 68,000 Lawsuits Filed Already

More than 68,000 women across the U.S. have filed lawsuits at the federal and state levels against manufacturers of transvaginal mesh patches, including:

What Should You Do?

If you have suffered complications due to the implantation of a transvaginal patch to treat POP or SUI, you are not alone, and may have a right to compensation. By filing a claim against the surgical mesh manufacturer, you could receive compensation for medical costs, lost wages, other financial burdens and for the pain and suffering caused by this defective medical device. You will also send a clear message to the manufacturer that it is unacceptable to sell medical devices that harm innocent people.

Some of the more common polypropylene mesh products of concern are for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are:

CR Bard (with Sofradim Production S.A.S. and/or Tissue Science Laboratories Limited)

Ethicon/Johnson & Johnson

American Medical Systems

Boston Scientific

Coloplast (with Mpathy and/or Mentor)




Contact Us

Contact the experienced medical device lawyers of Childers, Schlueter & Smith, LLC. for a free initial consultation. We will listen to your story and explain your legal rights to help you choose the best course of action for your claim.